The Philippine Heart Center is a hospital in Central, Quezon City, Philippines, specializing in the treatment of heart ailments. It was established in 1975.

During the past decade, Philippine Heart Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Philippine Heart Center" #1 sponsor was "Actelion" with 3 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Population Health Research Institute" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Philippine Heart Center" #1 collaborator was "Bayer" with 1 trials as a collaborator and "University of Cape Town" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Philippine Heart Center" are "Pulmonary Arterial Hypertension" (4 trials), "Kidney Disease, Chronic" (1 trials), "Pneumococcal Disease" (1 trials) and "Rheumatic Heart Disease" (1 trials). Many other conditions were trialed in "Philippine Heart Center" in a lesser frequency.

Most popular intervention types in "Philippine Heart Center" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BI 690517" (1 trials), "Empagliflozin" (1 trials), "Macitentan" (1 trials), "Macitentan 10 mg" (1 trials) and "Macitentan 10 mg tablet, once daily." (1 trials). Other intervention names were less common.

The vast majority of trials in "Philippine Heart Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Philippine Heart Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Philippine Heart Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Philippine Heart Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".